In the last trading session, 8.34 million shares of the Windtree Therapeutics Inc (NASDAQ:WINT) were traded, and its beta was 0.68. Most recently the company’s share price was $2.31, and it changed around -$0.6 or -20.79% from the last close, which brings the market valuation of the company to $1.62M. WINT currently trades at a discount to its 52-week high of $737.43, offering almost -31823.38% off that amount. The share price’s 52-week low was $2.90, which indicates that the current value has fallen by an impressive -25.54% since then.

Windtree Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 3.00. If we narrow it down even further, the data shows that 0 out of 1 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 1 recommended WINT as a Hold, whereas 0 deemed it a Buy, and 0 rated it as Underweight. Windtree Therapeutics Inc is expected to report earnings per share of -46 for the current quarter.

Windtree Therapeutics Inc (NASDAQ:WINT) trade information

Instantly WINT has showed a red trend with a performance of -20.79% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 4.29 on recent trading dayincreased the stock’s daily price by 46.15%. The company’s shares are currently down -86.80% year-to-date, but still down -37.36% over the last five days. On the other hand, Windtree Therapeutics Inc (NASDAQ:WINT) is -64.70% down in the 30-day period.

Windtree Therapeutics Inc (NASDAQ:WINT)’s Major holders

Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund were the top two Mutual Funds as of Dec 31, 2024. The former held 1.18 shares worth $2550.0, making up 0.00% of all outstanding shares. On the other hand, Vanguard Extended Market Index Fund held roughly 46.0 shares worth around $99.0, which represents about 0.00% of the total shares outstanding.